|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.890 HKD | -0.58% |
|
-4.44% | -18.27% |
| 06-18 | CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA | MT |
| 06-18 | CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.11B | |||||
| 992B | |||||
| 564B | |||||
| 391B | |||||
| 330B | |||||
| 280B |
Select your edition
All financial news and data tailored to specific country editions
